MedPath

Treatment of Heavy Menstrual Bleeding (periods) with Unani medicine Sharbat Anjbar

Phase 3
Conditions
Health Condition 1: N920- Excessive and frequent menstruation with regular cycle
Registration Number
CTRI/2019/02/017823
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Non- gravid- non menopausal females with age 25-45years.

2. Patients with Heavy menstrual bleeding as indicated by PBAC score of 100 or more

Exclusion Criteria

1. Patients with irregular and inter-menstrual bleeding.

2. Patients on Anticoagulant or Anti platelet medication.

3. Heavy Menstrual Bleeding with structural abnormality (e.g. fibroid, polyp etc) with

symptoms such as inter-menstrual or post-coital bleeding

4. Patients presenting with Heavy Menstrual Bleeding since menarche up to 3 years.

5. Patients with a personal or family history suggesting a coagulation disorder.

6. Patients using OCPs and IUCD.

· Patients with illness requiring long term treatment e.g. Hypertension, TB etc.

7. Patients with thyroid disorder.

8. Patients with BMI >30

9. Patients with Heavy Menstrual Bleeding taking Hormone Replacement Therapy.

10. Patients with severe anemia (Hb% less than 7g/dL)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath